The mechanisms underlying these effects are diverse, primarily involving modulation of the mTOR signaling pathway, leading to reduced tumor cell proliferation, cell cycle arrest, enhanced apoptosis, metabolic reprogramming of the tumor microenvironment, suppression of immune tolerance, and improved cytotoxic immune responses. The gene discussed is MTOR; the disease is neoplasm.